Make An Appointment

Or
Physician Location Contact

Clinical Trials

One of the benefits of receiving care from a Skyline Urology expert is access to a variety of clinical trials for which you may be eligible.  Clinical trials are research-based studies led by a Skyline urologist who is dedicated to developing new therapies for the patients who need them. 

Skyline currently has active trials involving new oral or IV drugs to treat advanced prostate cancer and overactive bladder, as well as a trial of treatment for bladder cancer.  Other medical therapies and immunotherapy trials are being studied in the treatment of erectile dysfunction (ED), benign prostatic hyperplasia (BPH) and Peyronie’s disease, among other conditions.

As in all of our Skyline Urology activities, patient safety is our highest priority.  Rigorous oversight by an institutional review board (IRB) is a key component to ensuring the safety of our patients and the integrity of the study.

Most of our clinical studies are part of larger, national trials sponsored by the National Cancer Institute or they may be sponsored by a large corporate entity that produces medical devices or products or new drugs to combat major diseases.  More specifically, clinical trials may involve:

Chemotherapy – to develop new drug therapies or more effective ways of utilizing new drugs or combinations of drugs.

Medical devices – to develop new, better ways of diagnosing cancer earlier and to treat certain urologic conditions.  For example, a medical device is being developed for the clitoris, to treat overactive bladder in women.

Surgical devices – to perform increasingly sophisticated surgical procedures with minimal side effects.

Genetic testing – to help physicians better understand the profile of a tumor and predict how aggressively it may be growing.

Clinical trials are carefully designed studies conducted with the goal of gaining new knowledge and improving therapies for patients. Eligibility criteria are carefully defined for each trial, making the study available for particular patient populations.

The three phases of clinical trials for drug therapies include:

Phase I – a relatively small group of participants involved in a study to determine the safety of a particular drug.

Phase II – usually involves a larger group of participants to determine the optimal dosage of a particular drug.

Phase III – the largest group or cohort of participants is followed to evaluate both the safety of the drug and its effectiveness.